Briacell Historical Valuation
| BCTX Stock | USD 0.62 0.03 4.62% |
Some fundamental drivers such as market cap or Briacell Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Briacell Therapeutics valuation indicators such as Working Capital of 357.4 K or Enterprise Value of 77 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Briacell Therapeutics's future value.
Briacell |
About Briacell Valuation Data Analysis
Valuation is the financial process of determining what Briacell Therapeutics is worth. Briacell Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Briacell Therapeutics valuation ratios help investors to determine whether Briacell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Briacell with respect to the benefits of owning Briacell Therapeutics security.
Briacell Therapeutics Valuation Data Chart
Working Capital
The difference between a company's current assets and current liabilities, indicating the liquidity and operational efficiency of the business.Enterprise Value
Enterprise Value (or EV) is usually referred to as Briacell Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Briacell Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Briacell Therapeutics value than its market capitalization because it takes into account all of Briacell Therapeutics Corp existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Most indicators from Briacell Therapeutics' valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Briacell Therapeutics current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Briacell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Market Cap is likely to rise to about 97.1 M in 2024. Enterprise Value is likely to rise to about 77 M in 2024
| 2023 | 2024 (projected) | Working Capital | 402.0K | 357.4K | Market Cap | 92.5M | 97.1M |
Briacell Therapeutics valuation accounts Correlations
Briacell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Briacell Therapeutics valuation accounts Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.8M | 77.8M | 99.9M | 102.8M | 92.5M | 97.1M | |
| Enterprise Value | 7.0M | 20.6M | 58.8M | 81.5M | 73.4M | 77.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Briacell Stock Analysis
When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.